ID: ALA2058713

Max Phase: Preclinical

Molecular Formula: C17H29NO2

Molecular Weight: 279.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OCCCCCCCCCCCCOc1cccnc1

Standard InChI:  InChI=1S/C17H29NO2/c19-14-9-7-5-3-1-2-4-6-8-10-15-20-17-12-11-13-18-16-17/h11-13,16,19H,1-10,14-15H2

Standard InChI Key:  GJEBVUZJIDIFSS-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania mexicana 936 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 279.42Molecular Weight (Monoisotopic): 279.2198AlogP: 4.35#Rotatable Bonds: 13
Polar Surface Area: 42.35Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.80CX LogP: 4.04CX LogD: 4.04
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.55Np Likeness Score: -0.41

References

1. García Liñares G, Parraud G, Labriola C, Baldessari A..  (2012)  Chemoenzymatic synthesis and biological evaluation of 2- and 3-hydroxypyridine derivatives against Leishmania mexicana.,  20  (15): [PMID:22781310] [10.1016/j.bmc.2012.06.028]

Source